PwC Medical Device Compliance Survey Discussion of Survey Results.

Slides:



Advertisements
Similar presentations
4.02 Compliance Training Brian A. Dahl Senior Counsel Takeda Pharmaceuticals North America, Inc. November 14, 2003.
Advertisements

Introduction to Existing State Disclosure Laws and Regulations Summit on Disclosure, Transparency and Aggregate Spend For Drug, Device and Biotech Companies.
MONITORING OF SUBGRANTEES
VCOM Conflict of Interest Policy Overview of Financial Conflict of Interest Related to Research December 4, 2013.
Financial Conflict of Interest July 2012 rev
Business & Travel Expense Policy: An Overview
Continuing Professional Development Conflict of Interest This presentation has been developed by the COI Working Group to assist in the implementation.
European Union of Medical Specialists November 18, 2011 Conference John McLoughlin Chairman, European Medical Technology Industry Association (EUCOMED)
Pharmaceutical Compliance Current Trends: Hot Button Issues to Look at this Year in Sales, Marketing, Clinical, Medical Affairs and Government Pricing.
Presented by: David Baird KSBA Interim Executive Director REVIEW OF THE AUDITOR EDELEN REPORT.
QUALITY ASSURANCE AND IMPROVEMENT PROGRAM (QAIP)
EMS Auditing Definitions
ASPEC Internal Auditor Training Version
ISA 220 – Quality Control for Audits of Historical Financial Information
Quality Representative Training Version
Promoting Objectivity in Research by Managing, Reducing, or Eliminating Conflicts of Interest UT HOP UT HOP The University of Texas at Austin.
Internal Auditing and Outsourcing
The Third Annual Medical Device Regulatory, Reimbursement and Compliance Congress Compliance Best Practices in a Post Orthopedic Environment David Matyas.
Exploring the Accreditation Criterion 1-15 BEST PRACTICES.
Financial Resource Management Recommended Best Practices Training for Volunteers and Support Groups.
VCU School of Medicine Policy on Industry Relations Effective July 1, 2009.
Voluntary Codes MassMEDIC Meeting Are You Ready to Comply with Massachusetts’ New Pharmaceutical and Medical Device Code of Conduct Law? Linda D. Bentley,
© 2008 Foley Hoag LLP. All Rights Reserved. 1 The New Massachusetts Pharmaceutical & Medical Device Marketing Regulations How to Address and Overcome Likely.
Planning an Audit The Audit Process consists of the following phases:
PwC Internal Control Reports: Facts, Myths and Best Practices FIRMA National Risk Management Training Conference – San Francisco, CA Wednesday March 31,
How to Develop Internal Monitoring Programs SEVENTH ANNUAL PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS AND BEST PRACTICES FORUM Stephen F. Mohr Global.
Pitfalls and Lessons Learned: Advanced Implementation Strategies for a Compliant Grant Process National CME Audioconference December 9, 2008.
Joint Forum of Financial Market Regulators Forum conjoint des autorités de réglementation du marché financier Guidelines for Capital Accumulation Plans.
PURE MICHIGAN STATE TRADE and EXPORT PROMOTION (STEP) PROGRAM For Global Business Club of Mid-Michigan November 17, 2011 By Deanna Richeson MEDC Director,
PwC *connectedthinking Monitoring and Auditing Around Government Pricing Peter J. Claude PricewaterhouseCoopers LLP November 7, 2005.
Reviewing Totality Close Out Reports. Why Reviewing Close Out Reports is CRITICAL! Information uploaded by supplier is utilized for State Reporting purposes.
PwC Medical Device Compliance Survey Discussion of Survey Results March 30, 2006.
The Ninth Annual Pharmaceutical Regulatory Compliance Congress and Best Practices Forum Thomas E. Costa Bristol-Myers Squibb Company This presentation.
PwC 2007 Medical Technology Industry Benchmarking Survey Discussion of Survey Results March 28, 2007.
EFPIA and IFPMA Code Compliance Strategies Richard BERGSTRÖM Chair, EFPIA Code Steering Committee Chair, IFPMA Code Compliance Network Presentation at.
Partners Conflict of Interest Policy and Reporting October 11, 2012.
Chapter 20 Additional Assurance Services: Other Information McGraw-Hill/IrwinCopyright © 2014 by The McGraw-Hill Companies, Inc. All rights reserved.
1 Harvard University Cambridge, MA March 29, 2007 Medical Device Congress AdvaMed’s Efforts to Promote Compliance Christopher L. White, Esq. Executive.
Amendments to the Work Permit Rules: Problematic Issues Alex Nisengolts 28 April 2011.
ISO Environmental Management Systems 1 ISO LEGAL AND OTHER REQUIREMENTS.
OFFICE OF INDEPENDENT EDUCATION & PARENTAL CHOICE Budget and Finance 2009 CSP Grant OFFICE OF INDEPENDENT EDUCATION & PARENTAL CHOICE Budget and Finance.
COCIR Code of Conduct Nicole DENJOY COCIR Secretary General.
Pwc Fifth Annual National Congress on Health Care Compliance Pharmaceutical Sales and Marketing: Are You Afraid to Look Under the Rocks? Michael P. Swiatocha.
Session 1.01 US Healthcare Professionals Abroad – Issues and Practical Solutions Caroline West – Senior VP, Chief Compliance and Risk Officer Shire Pharmaceuticals.
Japan Fair Competition Code for Medical Devices Industry (JFCC-MDI)
Compliance Issues in Dealing With Drug and Device Manufacturers Presentation to The Sixth Annual National Congress On Health Care Compliance Paul E. Kalb,
18-1 Copyright © 2016 McGraw-Hill Education. All rights reserved. No reproduction or distribution without the prior written consent of McGraw-Hill Education.
HSAB Audit Findings Addressed Lisa Tennyson, Grants Administrator OMB July 2012.
ICAJ/PAB - Improving Compliance with International Standards on Auditing Planning an audit of financial statements 19 July 2014.
1 The Implementation of Fair Market Value What can we learn from recent enforcement actions? Debjit Ghosh Life Sciences Advisory Services Huron Consulting.
Medical Device Compliance Congress: Global Device Codes Roundtable - Australia Anne Trimmer.
The IVD Australia Code of Conduct Edition 2.1
Conflict of Interest Disclosure
Conflict of Interest Disclosure
Chapter 20 Additional Assurance Services: Other Information
Analysis of the Proposed Sunshine Rule: Legal Considerations
The NYS non-Profit revitalization act
University of Pittsburgh
The Most Important Element to Assure That Your Sales and Marketing Compliance Program is Working Effectively: Monitoring and Auditing Kelly B. Freeman,
The Third Annual Medical Device Regulatory, Reimbursement and Compliance Congress Beyond the DOJ: Compliance Best Practices in the Orthopedic Environment.
Conflicts of Interest In the past 2 years I have been an employee of:
Alexandros Dimitriadis
Lilly Grant Funding Disclosure May 27, 2008
Medical Device, Regulatory and Reimbursement Compliance Congress
Conflict of Interest Disclosure
2007 Medical Technology Industry Benchmarking Survey
Industry Induction Course
Conflict of Interest Disclosure
Benchmarking Compliance for the Healthcare Industry
Presentation transcript:

PwC Medical Device Compliance Survey Discussion of Survey Results

PricewatherhouseCoopersKing & Spalding LLP2 Survey Background PwC conducted an in-depth benchmarking survey on medical device industry compliance practices Together with King & Spalding and Compliance-Alliance, PwC: Worked with an advisory committee of device company compliance personnel to ensure survey questions were relevant Invited 30 medical device companies to participate in the 35- question survey; 20 agreed to participate Analyzed the data to identify the better practices in the industry

PricewatherhouseCoopersKing & Spalding LLP3 Survey Demographics Distribution of 2004 Global Sales for the twenty firms that participated in the survey:

PricewatherhouseCoopersKing & Spalding LLP4 General Compliance Environment The industry has overwhelmingly adopted the AdvaMed Code About two-thirds of companies presidents or CEOs have personally endorsed the AdvaMed Code in a written statement addressed to company employees and/or customers. The general impression among the companies surveyed is that compliance with the AdvaMed Code varies depending on company size, market presence, and geography

PricewatherhouseCoopersKing & Spalding LLP5 Gifts, Meals, and Entertainment Survey Results Companies have implemented controls over gifts for HCPs to varying degrees Practices mixed as to whether pre-purchase approval occurs centrally or locally Value of individual gifts vs. frequency of gifts Restriction of the types of interactions in which gifts can be given Variability in definition of reasonable/modest meals and entertainment Better Practices List of pre-approved gifts from which reps can purchase, and gift-giving is only permitted for specified interactions Quantified measures of reasonable/modest Gift/meal/entertainment limitations are applied to all employees, regardless of title Gift/meal/entertainment expenses are tracked by HCP in aggregate spend analyses

PricewatherhouseCoopersKing & Spalding LLP6 Engagement of Healthcare Professionals Survey Results Most companies have instituted robust controls over the engagement of healthcare professionals, including: -Approaches to determining Fair Market Value (FMV). -Ensuring value is received for engagement of HCPs. Better Practices Contracts for each engagement that include anti-kickback language Articulated standards for consistent determination of FMV Limits on frequency and value of engagements Domestic coach travel, International business travel Evidence obtained of services received and used Establish annual limits on total value of compensation paid to HCPs Reduce involvement of sales force in selecting participants

PricewatherhouseCoopersKing & Spalding LLP7 Educational and Research Grants Survey Results Companies continue to place restrictions around the involvement of the sales force for the distribution, receipt, processing, and approval of grant requests There is growing use of grants committees for approval of educational/ charitable grants and research grants. While sales is decreasingly owning budgets, sales and marketing are major participants on the committees: # of Companies at which the Functional Area is represented on the Grant Committee

PricewatherhouseCoopersKing & Spalding LLP8 Educational and Research Grants, continued Survey Results, continued Charitable Contributions Most companies have established controls over charitable grants, with articulated selection and giving criteria. The sales force is excluded from the decision making process. Many companies have monitoring processes in place to ensure that denied educational or research grant requests are not resubmitted as charitable grant requests.

PricewatherhouseCoopersKing & Spalding LLP9 Educational and Research Grants, continued Better Practices Involvement of sales force is limited to guiding requestors on how to initiate a request Requests are supported by a request letter, and business purpose is documented Requests are reviewed by a grants committee (or separate committees for research and non-research grants) or Compliance/Legal Proof of performance is required, and payments are made directly to the recipient

PricewatherhouseCoopersKing & Spalding LLP10 Speaker Programs Survey Results Most companies track and obtain detailed information on attendees Sales Force commonly involved in identification/selection of HCPs for speaker bureaus Most companies review and/or approve speaker program content prior to event: Review by Legal, Regulatory, Medical/Scientific, and/or Compliance functions Better Practices Speakers and speaker content pre-trained and pre-qualified, with honoraria determined through FMV calculation Policies on meals and entertainment applicable to speaker program events Tracking of attendance of HCPs at events On-site compliance monitoring of speaker programs

Questions?

FP-FP A © 2006 PricewaterhouseCoopers. All rights reserved. PricewaterhouseCoopers refers to the network of member firms of PricewaterhouseCoopers International Limited, each of which is a separate and independent legal entity. PwC